REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/07/2025
Back to search
Official data from USPTO
LA PHARMA S.R.L.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
04/08/2025
Trademark type
Combined
Nice classes
5
Filing date
09/13/2019
Registration date
04/07/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/07/2020
Last transaction
04/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/05/2019
First use in commerce
05/05/2019
Drawing code
3
Owner type
16
Owner location
MARLTON, NJ
Examiner
HESIK, APRIL
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of an image of a lion with a crown, below the lion the words "LA PHARMA S.r.l." are written surround the lion forming a semi circle. The other part of the circle is made by two curvy lines, one at each side which end just before the crown.
Holders and representatives
Holders
LA PHARMA S.R.L LLC
Rothwell Formulations Private Limited
Representatives
ABRAHAM LICHY THE LICHY LAW FIRM, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Adrenal hormone preparations; Hormonal preparations; Hormone replacement therapy preparations; Hormones; Hormones for medical purposes; Human growth hormone; Mixed hormone preparations; Natural remedy preparations for the treatment of gastro-intestinal conditionshormonal and chemical imbalancessleep disorders; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Preparations for the suppression of hormones; Steroids; Thyroid and para-thyroid hormone preparations
Publications
History of USPTO decisions and trademark events.
16 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/14/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/21/2020
PUBO
PUBLISHED FOR OPPOSITION
01/21/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2020
ALIE
ASSIGNED TO LIE
12/19/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/16/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/16/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/16/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/16/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/16/2019
DOCK
ASSIGNED TO EXAMINER
12/15/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/24/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/22/2019
NWAP
NEW APPLICATION ENTERED
09/17/2019
Continuous trademark protection
Get notified about every new filing that threatens LA PHARMA S.R.L. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.